Tiny Alpha-Emitting seeds show promise for Hard-to-Treat cancers
NCT ID NCT03737734
First seen Apr 10, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study tests a device that delivers a special type of radiation (alpha rays) directly into tumors. It is for people with skin, mouth, or soft tissue cancers that have not responded to standard treatments or who cannot have surgery or regular radiation. The goal is to see if the treatment can shrink tumors safely. About 30 participants are being followed to track tumor response and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Davidof Cancer Institution at the Rabin Medical Center Israel
Petah Tikva, 49100, Israel
Conditions
Explore the condition pages connected to this study.